Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516374 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Hard CopyAdd to Basket
Live Chat Live Help Software for Website

Haematological Characteristics of myeloid acute leukaemia in Tunisia. Edition No. 1

VDM Publishing House, July 2009, Pages: 76


  Description  
   Authors   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

The purpose of this study is a bio-clinical review according to the WHO recommendations in 153 cases of LAM. The patients were aged 2 months to 90 years with sex ratio (M/F) of 1,22.The morphologic conclusion was difficult in 12% cases. Presence of dysplasia is noted in 50% of cases with multilineage dysplasia in 42% of cases. Our results showed cloned chromosomal abnormalities in. 57% of cases( t(8;21): 12%, t(15 ;17): 10%, Inv16: 1,3%, 11q23 :2,6% et complex karyotype:14,3%).In 69% of cases with avec multilineage dysplasia, the karyotype was normal. 3 cases of LAM were noted at patients treated for breast cancer with chirurgic chemotherapy and radiotherapy 3, 4 et 5 years after treatment (LAM3 with t(15;17), LAM4 with genetic abnormalities of chromosomes3,5,7,8,9,14 et 16 et LAM 6 with genetic abnormalities of chromosomes4,7,12,14,19 et 21).In WHO classification, cytology is essential in diagnosis of LAM even if the karytype have an important prognostic value. Research of signs of dysplasia lineage after lineage constitutes an important microscopic work and it is difficult to quantify dysplasia when the lineage is poor.



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds